- NCIt
- C132146
Loading cancer entity…
Loading cancer entity…
Clinical trials
900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (101)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03834662 | A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies | completed | Phase 1 | 19 | Bristol-Myers SquibbINDUSTRY | 2 | Nov 19, 2024 | clinicaltrials |
| NCT04870645 | Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis | completed | N/A | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 6, 2024 | clinicaltrials |
| NCT01359982 |
| Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects(DINAMIC) |
| completed |
| Phase 1 |
| 26 |
| EpicentRx, Inc.INDUSTRY |
| 1 |
| Nov 1, 2024 |
| clinicaltrials |
| NCT04742595 | Viral Specific T Cell Therapy for COVID-19 Related Pneumonia | completed | Early Phase 1 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT03323034 | Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 30 | Children's Oncology GroupNETWORK | 1 | Oct 22, 2024 | clinicaltrials |
| NCT04908046 | A Study of HMPL-295S1 in Patients With Advanced Malignant Solid Tumors | completed | Phase 1 | 47 | HutchmedINDUSTRY | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05198089 | Development of a Digital Tool, MyInspiration, for the Improvement of Spiritual Well-Being in Patients with Cancer | completed | Phase 1 | 52 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 8, 2024 | clinicaltrials |
| NCT05717101 | Patient Registry in Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound Imaging | completed | — | 4 | Mayo ClinicOTHER | 1 | Sep 24, 2024 | clinicaltrials |
| NCT05058339 | Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer | completed | — | 223 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05224271 | Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study | completed | — | 18 | Mayo ClinicOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06582030 | Stop Addiction Stigma | completed | N/A | 93 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT04067960 | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer | completed | Early Phase 1 | 197 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT02595866 | Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Aug 9, 2024 | clinicaltrials |
| NCT02020707 | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers | completed | Phase 1 | 43 | Mayo ClinicOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT03320330 | Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors | completed | Phase 1 / Phase 2 | 26 | Children's Oncology GroupNETWORK | 1 | Jul 15, 2024 | clinicaltrials |
| NCT04532372 | Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy | completed | Phase 1 / Phase 2 | 2 | City of Hope Medical CenterOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05036408 | Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological Solutions | completed | N/A | 16 | City of Hope Medical CenterOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05054998 | Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases | completed | Phase 4 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT05950399 | Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk | completed | N/A | 52 | Mayo ClinicOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT03890731 | A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed | completed | Phase 2 | 6 | BayerINDUSTRY | 5 | Apr 2, 2024 | clinicaltrials |
| NCT03590054 | Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies | completed | Phase 1 | 35 | Rahul AggarwalOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT01738139 | Ipilimumab and Imatinib Mesylate in Advanced Cancer | completed | Phase 1 | 68 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT03525925 | Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors | completed | Phase 1 | 16 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT05083338 | Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy | completed | — | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT04439006 | Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization | completed | Phase 1 | 10 | Jennifer WoyachOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT05930457 | Study of 64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors | completed | Phase 1 | 15 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT01709435 | Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 2 | Dec 22, 2023 | clinicaltrials |
| NCT02808650 | Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 30 | Children's Oncology GroupNETWORK | 1 | Dec 20, 2023 | clinicaltrials |
| NCT05814835 | First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid Tumors | completed | Phase 1 | 14 | Chinese PLA General HospitalOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT05793957 | Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms | completed | N/A | 50 | OHSU Knight Cancer InstituteOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT03229278 | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma | completed | Phase 1 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Dec 6, 2023 | clinicaltrials |
| NCT03831295 | SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid Malignancies | completed | Phase 1 | 12 | Ronald LevyOTHER | 1 | Nov 22, 2023 | clinicaltrials |
| NCT04491409 | Perioperative Care in the Cancer Patient -1, ARCA-1 Study | completed | — | 229 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT03784677 | A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors | completed | Phase 1 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT02304458 | Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas | completed | Phase 1 / Phase 2 | 140 | National Cancer Institute (NCI)NIH | 2 | Oct 17, 2023 | clinicaltrials |
| NCT02780804 | Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Oct 17, 2023 | clinicaltrials |
| NCT03253679 | AZD1775 in Treating Patients With Advanced Refractory Solid Tumors With CCNE1 Amplification | completed | Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Oct 17, 2023 | clinicaltrials |
| NCT03017833 | Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers | completed | Phase 1 | 31 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT01827384 | MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations | completed | Phase 2 | 208 | National Cancer Institute (NCI)NIH | 1 | Sep 29, 2023 | clinicaltrials |
| NCT02095132 | Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 / Phase 2 | 76 | National Cancer Institute (NCI)NIH | 2 | Sep 26, 2023 | clinicaltrials |
| NCT01376505 | Vaccine Therapy in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 65 | Robert WesolowskiOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT02317874 | Testing the Addition of the Anti-Cancer Drug Talazoparib to the Combination of Carboplatin and Paclitaxel for the Treatment of Advanced Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Aug 29, 2023 | clinicaltrials |
| NCT04697524 | Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer | completed | N/A | 30 | University of California, San FranciscoOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT04456140 | Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study | completed | Phase 1 | 230 | Mayo ClinicOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT02847130 | Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology | completed | — | 530 | Children's Oncology GroupNETWORK | 2 | Jul 19, 2023 | clinicaltrials |
| NCT04337203 | Shared Healthcare Actions and Reflections Electronic Systems in Survivorship | completed | N/A | 40 | Wake Forest University Health SciencesOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT04902144 | Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | completed | N/A | 6 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 9, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Nov 19, 2024source: clinicaltrials